Cargando…
Linking Gba1 E326K mutation to microglia activation and mild age-dependent dopaminergic Neurodegeneration
Mutations in the GBA1 gene have been identified as a prevalent genetic risk factor for Parkinson’s disease (PD). GBA1 mutations impair enzymatic activity, leading to lysosomal dysfunction and elevated levels of α-synuclein (α-syn). While most research has primarily focused on GBA1’s role in promotin...
Autores principales: | Kweon, Sin Ho, Ryu, Hye Guk, Park, Hyeonwoo, Lee, Saebom, Kim, Namshik, Kwon, Seung-Hwan, Ma, Shi-Xun, Kim, Sangjune, Ko, Han Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515932/ https://www.ncbi.nlm.nih.gov/pubmed/37745332 http://dx.doi.org/10.1101/2023.09.14.557673 |
Ejemplares similares
-
c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation
por: Lee, Saebom, et al.
Publicado: (2022) -
α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018) -
The Association between E326K of GBA and the Risk of Parkinson's Disease
por: Huang, Yongpan, et al.
Publicado: (2018) -
The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
por: Smith, Laura J, et al.
Publicado: (2022) -
Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease
por: Kim, Soojin, et al.
Publicado: (2021)